About Immuron
Immuron (ASX:IMC), (NASDAQ:IMRN) is an Australian-based biopharmaceutical company focusing on the research, development, and commercialization of oral immunotherapy products. Immuron's main projects aim to tackle various gastrointestinal and liver diseases, leveraging its unique platform technology to produce oral immune-modulating polyclonal antibodies. Among its leading products is Travelan, an over-the-counter product for the prevention of travelers' diarrhea, and a pipeline of pre-clinical candidates targeting severe liver diseases, including NASH (Non-alcoholic steatohepatitis). Immuron's objective is to harness its proprietary technology to create therapies that improve health outcomes for patients worldwide dealing with immune-mediated and infectious diseases, constantly striving to expand its product portfolio and research capabilities to address unmet medical needs.
Snapshot
Operations
Produtos e/ou serviços de Immuron
- Travelan, an over-the-counter product aimed at preventing travelers' diarrhea, utilizing antibodies to combat harmful bacteria.
- IMM-124E, a clinical-stage project targeting immune-mediated and inflammatory diseases, including NASH (Non-alcoholic steatohepatitis).
- IMM-529, a therapeutic candidate designed for Clostridium difficile infections, focusing on both prevention and treatment of this severe gastrointestinal infection.
- A research initiative focused on developing treatments for colitis and irritable bowel syndrome, leveraging its expertise in immunotherapy and gut health.
- Partnerships with the U.S. Department of Defense and Naval Medical Research Center to develop vaccines and treatments against enterotoxigenic Escherichia coli and Shigella.
- Collaboration with leading universities and research institutions to explore potential therapeutic applications of its technology platform for infectious diseases and immune modulation.
equipe executiva do Immuron
- Mr. Steven George Lydeamore CPA, M.B.A.Chief Executive Officer
- Dr. Jerry Kanellos Ph.D.Chief Scientific Officer
- Mr. Flavio PalumboChief Commercial Officer
- Mr. Philip Allen Hains BBus(Acc), C.A., M.B.A.CFO & Company Secretary
- Mr. David LyonHead of Marketing